56 related articles for article (PubMed ID: 25156817)
1. Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.
Xiong Y; Bai Y; Leong N; Laughlin TS; Rothberg PG; Xu H; Nong L; Zhao J; Dong Y; Li T
Diagn Pathol; 2013 Feb; 8():27. PubMed ID: 23419122
[TBL] [Abstract][Full Text] [Related]
2. [Investigation on the Possibility of EGFR Mutation Testing on DNA Extracted from Fixation Liquid of Lung Cancer Biopsy].
Liao X; Gu Y; Jiang J
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):433-439. PubMed ID: 31315782
[TBL] [Abstract][Full Text] [Related]
3. Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility.
Ghous G; Ijaz K; Esebua M; Layfield LJ
Diagn Cytopathol; 2024 Feb; 52(2):123-130. PubMed ID: 38017653
[TBL] [Abstract][Full Text] [Related]
4. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
Yaghoubi Naei V; Bordhan P; Mirakhorli F; Khorrami M; Shrestha J; Nazari H; Kulasinghe A; Ebrahimi Warkiani M
Ther Adv Med Oncol; 2023; 15():17588359231192401. PubMed ID: 37692363
[TBL] [Abstract][Full Text] [Related]
5. Ultra-rapid Idylla™
Qiu T; Zhang F; Zheng B; Feng Z; Li W; Zeng H; Chu L; Ying J
Front Oncol; 2023; 13():1064487. PubMed ID: 37064089
[TBL] [Abstract][Full Text] [Related]
6. Advances in Microfluidics for the Implementation of Liquid Biopsy in Clinical Routine.
Teixeira A; Carneiro A; Piairo P; Xavier M; Ainla A; Lopes C; Sousa-Silva M; Dias A; Martins AS; Rodrigues C; Pereira R; Pires LR; Abalde-Cela S; Diéguez L
Adv Exp Med Biol; 2022; 1379():553-590. PubMed ID: 35761007
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
[TBL] [Abstract][Full Text] [Related]
8. High concordance of EGFR mutation status between sputum and corresponding tissue specimens of late-stage lung cancers using amplification refractory mutation system-PCR.
Su F; Fu Y; Wu Q; Zheng K; Tang Y; Su X; Wang Y; Jiang L
Int J Clin Exp Pathol; 2018; 11(5):2683-2690. PubMed ID: 31938383
[TBL] [Abstract][Full Text] [Related]
9. Identification of EGFR mutations in cytological specimens of non-small cell lung carcinoma from a single institute.
Wang W; Tang Y; Li J; Zhang Y; Zou Y; Su X
Int J Clin Exp Pathol; 2018; 11(2):929-935. PubMed ID: 31938186
[TBL] [Abstract][Full Text] [Related]
10. EGFR mutations subset in Chinese lung squamous cell carcinoma patients.
Sun Y; Yin X; Wen MM; Zhang J; Wang XJ; Xia JH; Zhang YN; Zhang ZP; Li XF
Mol Med Rep; 2018 Jun; 17(6):7575-7584. PubMed ID: 29620244
[TBL] [Abstract][Full Text] [Related]
11. Detection of Rare Mutations in EGFR-ARMS-PCR-Negative Lung Adenocarcinoma by Sanger Sequencing.
Liang C; Wu Z; Gan X; Liu Y; You Y; Liu C; Zhou C; Liang Y; Mo H; Chen AM; Zhang J
Yonsei Med J; 2018 Jan; 59(1):13-19. PubMed ID: 29214771
[TBL] [Abstract][Full Text] [Related]
12. Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.
Dong ZY; Zhai HR; Hou QY; Su J; Liu SY; Yan HH; Li YS; Chen ZY; Zhong WZ; Wu YL
Oncologist; 2017 Jan; 22(1):61-69. PubMed ID: 28126915
[TBL] [Abstract][Full Text] [Related]
13. Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer.
Wen M; Wang X; Sun Y; Xia J; Fan L; Xing H; Zhang Z; Li X
Onco Targets Ther; 2016; 9():1989-95. PubMed ID: 27103824
[TBL] [Abstract][Full Text] [Related]
14. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey.
Lee SH; Kim WS; Choi YD; Seo JW; Han JH; Kim MJ; Kim L; Lee GK; Lee CH; Oh MH; Kim GY; Sung SH; Lee KY; Chang SH; Rho MS; Kim HK; Jung SH; Jang SJ;
J Pathol Transl Med; 2015 Nov; 49(6):481-8. PubMed ID: 26459407
[TBL] [Abstract][Full Text] [Related]
16. ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimens.
Liu J; Zhao R; Zhang J; Zhang J
J Cancer Res Clin Oncol; 2015 Feb; 141(2):221-7. PubMed ID: 25156817
[TBL] [Abstract][Full Text] [Related]
17. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
Sun PL; Jin Y; Kim H; Lee CT; Jheon S; Chung JH
Cancer Cytopathol; 2013 Jun; 121(6):311-9. PubMed ID: 23225576
[TBL] [Abstract][Full Text] [Related]
18. High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
Wu CY; Hou LK; Ren SX; Su B; Chen G
Asian Pac J Cancer Prev; 2014; 15(18):7885-9. PubMed ID: 25292082
[TBL] [Abstract][Full Text] [Related]
19. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.
Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL
J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
